| Product NDC: | 55154-4725 |
| Proprietary Name: | Bumetanide |
| Non Proprietary Name: | BUMETANIDE |
| Active Ingredient(s): | .25 mg/mL & nbsp; BUMETANIDE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55154-4725 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074332 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111116 |
| Package NDC: | 55154-4725-8 |
| Package Description: | 1 VIAL in 1 BAG (55154-4725-8) > 4 mL in 1 VIAL |
| NDC Code | 55154-4725-8 |
| Proprietary Name | Bumetanide |
| Package Description | 1 VIAL in 1 BAG (55154-4725-8) > 4 mL in 1 VIAL |
| Product NDC | 55154-4725 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | BUMETANIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20111116 |
| Marketing Category Name | ANDA |
| Labeler Name | Cardinal Health |
| Substance Name | BUMETANIDE |
| Strength Number | .25 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |